Holger Reithinger
Holger Reithinger (Chairman), ALLECRA THERAPEUTICS
Biotechnology
Clinical Research
France
Biography
Holger Reithinger (Chairman) is a General Partner at Forbion Capital Partners since 2010. He holds a PhD in Biochemistry, obtained at the Max-Planck-Institute of Biophysics. After his studies, Holger gained operational experience as a product development manager at Biometra/ Whatman Plc (now part of GE Healthcare). His career in Venture Capital started in 1997 as Investment Manager at Technologieholding VC GmbH, and more recently he was Partner at Global Life Science Ventures. Holger has served on the Boards of numerous life sciences companies including Epigenomics, MBT, 4SC, NeurogesX, Fibrex Medical, Agendia BV and Santaris A/S. Holger additionally holds board seats at Curetis NV, Cellnovo Group S.A.and Rigontec GmbH
Research Interest
Epigenomics
